Pfizer-BioNTech COVID-19 Vaccine Phase 3 Clinical Study Results

On December 10, 2020, Pfizer Inc. and BioNTech SE announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate. In the trial of 43,448 participants, who were 16 years and older, 21,720 of whom received BNT162b2 and 21,728 placebo, the two-dose regimen of 30 μg BNT162b2, which was given 21 days apart, was well-tolerated and demonstrated vaccine efficacy of 95% against COVID-19.Support us by using this link when you shop on Amazon:https://www.amazon.com/Amazon-5-000-Coins/dp/B0096E8EC2?&_encoding=UTF8&tag=yunghealth-20&linkCode=ur2&linkId=839688fa30022bf270af7be621af9863&camp=1789&creative=9325This video is based on original news release from Pfizer on December 10, 2020:https://bit.ly/3fT6jTaModels featured in this video:https://bit.ly/2MptQjMSUBSCRIBE to our channel:http://bit.ly/3pOwYUZ

Pfizer-BioNTech COVID-19 Vaccine Phase 3 Clinical Study Results

Description

Related Videos

Moderna to supply COVID-19 vaccine to Korea in May, WHO grants emergency use approval for Pfizer-BioNTech vaccine

#SentroBalita | Mass vaccination ng Russia vs COVID-19, sisimulan na sa susunod na linggo; COVID-19 vaccine ng Pfizer and Biontech, may emergency use authorization na mula sa U.K.

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

Pfizer-Biontech COVID vaccine, binigyan ng full approval ng US FDA | SONA

Breaking News: COVID vaccine ng Pfizer-BioNTech, may full approval na sa US FDA | Saksi

U.S. FDA revises guidelines for Pfizer/BioNTech COVID-19 vaccines following reports of side effects

Bakuna ng Pfizer-BioNTech, kauna-unahang COVID-19 vaccine na binigyan ng full approval ng US FDA | 24 Oras

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

#LagingHanda | Pfizer-Biontech COVID-19 vaccine, aprubado na ng FDA

Pfizer-BioNTech COVID-19 Vaccine Phase 3 Clinical Study Results

Description

Related Videos

Moderna to supply COVID-19 vaccine to Korea in May, WHO grants emergency use approval for Pfizer-BioNTech vaccine

#SentroBalita | Mass vaccination ng Russia vs COVID-19, sisimulan na sa susunod na linggo; COVID-19 vaccine ng Pfizer and Biontech, may emergency use authorization na mula sa U.K.

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

Pfizer-Biontech COVID vaccine, binigyan ng full approval ng US FDA | SONA

Breaking News: COVID vaccine ng Pfizer-BioNTech, may full approval na sa US FDA | Saksi

U.S. FDA revises guidelines for Pfizer/BioNTech COVID-19 vaccines following reports of side effects

Bakuna ng Pfizer-BioNTech, kauna-unahang COVID-19 vaccine na binigyan ng full approval ng US FDA | 24 Oras

FDA Finds Pfizer-BioNTech COVID Vaccine Candidate Is 95% Effective

#LagingHanda | Pfizer-Biontech COVID-19 vaccine, aprubado na ng FDA